Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
This randomized phase I trial studies the side effects and the best dose of
Se-methyl-seleno-L-cysteine or selenomethionine in preventing prostate cancer in healthy
participants. Chemoprevention is the use of certain drugs to keep cancer from forming. The
use of Se-methyl-seleno-L-cysteine or selenomethionine, two different types of selenium
compounds, may prevent prostate cancer from forming.